Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance)
      QxMD      Google Scholar   
Citation:
Support Care Cancer vol 26 (2) 643-650
Year:
2018
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
7
Parents:
2098   2223  
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
Health Outcome    
Pharmas:
 
Grants:
U10CA035101, U10CA035103, U10CA035113, U10CA035119, U10CA035195, U10CA035267, U10CA035269, U10CA035415, U10CA035431, U10CA035448, U10CA037404, U10CA037417, U10CA052352, U10CA063848, U10CA063849, U10CA180790, UG1CA189863, UG1CA189971.  
Corr. Author:
 
Authors:
                                 
Primary Study
N10C1
Secondary Studies:
Phases:
3
Keywords: